Antifibrillatory properties of hydrazine derivatives in experimental acute coronary insufficiency.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004285:Dogs; D006834:Hydrazines / Q000627:therapeutic use*; D007490:Iproniazid / Q000627:therapeutic use*; D007511:Ischemia / Q000188:drug therapy*; D007538:Isoniazid / Q000627:therapeutic use*; D011342:Procainamide / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000517:prevention & control*
D000889:Anti-Arrhythmia Agents; D006834:Hydrazines; D007490:Iproniazid; D011342:Procainamide; D007538:Isoniazid